At these prices, this is a honeypot target for takeover.
Looking at the potential and they progress so far with patents and success, these prices are peanuts for a big pharma.
It's a no brainer.
It will be a pity to see MSB getting taken over by a hostile takeover and then someone else making billions out of it.
NSB is most vulnerable at this stage.
I can think of 2 things that can save it now.
aGVHD adult trial funded by institutions as a research study. (some giveaway)
CLBP trial kicked off within 2023 in partnership with some big pharma with some good money coming in reducing our net debt position. (more give away).
This will give a boost to SP and even if there's a CR sometime, it won't be that bad.
Plus a SP rise will lessen the chances of hostile takeover.
These give aways now lets the compnay survive.
Pray, Rest, Believe!! ...whatever helps.
At these prices, this is a honeypot target for takeover. Looking...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5697 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
-0.010 ( 0.10 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.11 | $1.06 | 1181223 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MSB (ASX) Chart |